SCHEMBL8938401

SCHEMBL8938401

NS(=O)(=O)Nc1ccc(CCN2CCCC(OC(c3ccccc3)c3ccccc3)C2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.45
SLC6A4 P31645 4/20 0.45
SLC6A3 Q01959 4/20 0.45
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA5A P35218 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA13 Q8N1Q1 1/20 0.41
CA14 Q9ULX7 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
GRM5 P41594 1/20 0.41
GRM7 Q14831 1/20 0.41
GRM3 Q14832 1/20 0.41
DRD3 P35462 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938241 0.90 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3SIGMAR1GRM5
SCHEMBL8938516 0.89 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3SIGMAR1GRM5
SCHEMBL8938637 0.84 SIGMAR1 (0.51) SLC6A2SLC6A4SLC6A3SIGMAR1DRD3
SCHEMBL8938619 0.83 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3SIGMAR1DRD3
SCHEMBL8938352 0.82 DRD3 (0.51) SLC6A2SLC6A4SLC6A3GRM5GRM7
SCHEMBL8938360 0.81 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3SIGMAR1GRM5
SCHEMBL8938512 0.81 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3SIGMAR1DRD3
SCHEMBL8938477 0.81 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3SIGMAR1GRM5
SCHEMBL8938444 0.81 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3GRM5GRM7
SCHEMBL8938314 0.81 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3SIGMAR1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5534626-A SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST INTERMEDIATES PFIZER INC. (US) 1996-07-09 US disclosed
US-5410046-A Selective muscarinic receptor antagonists PFIZER INC. (US) 1995-04-25 US disclosed
US-5231104-A Anticholinergic PFIZER INC. (US) 1993-07-27 US disclosed
EP-0350309-B1 PIPERIDINE DERIVATIVES Pfizer Limited (GB) 1992-11-11 EP disclosed
US-5089505-A Anticholinergic agents PFIZER INC. (US) 1992-02-18 US disclosed
EP-0350309-A1 Piperidine derivatives Pfizer Limited (GB) 1990-01-10 EP disclosed